Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("MOOS, W")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 27

  • Page / 2
Export

Selection :

  • and

SELBST DIE ABWASSERWAERME WIRD GENUTZT: ENERGIEBEWUSSTE HAUSTECHNIK IM FERIENZENTRUM "GAUENPARK" = EVEN WASTE WATER HEAT CAN BE RECOVERED. ENERGY SAVING DEVICES IN THE "GAUENPARK" HOLIDAY RESORT = MEME LA CHALEUR DES EAUX USEES PEUT ETRE UTILISEE. EQUIPEMENT ENERGETIQUE DU CENTRE DE VACANCES "GAUENPARK"VON MOOS W.1979; SANIT. U. HEIZUNGSTECH.; DEU; DA. 1979; VOL. 44; NO 10; PP. 879-882Article

Determination of poloidal variation of the electron temperature and density in a tokamak plasma using VUV spectroscopyLIPPMANN, S; FINKENTHAL, M; MOOS, W et al.Physica scripta (Print). 1990, Vol 41, Num 4, pp 506-509, issn 0031-8949, 4 p.Article

Post-modification of peptoid side chains : [3+2] cycloaddition of nitrile oxides with alkenes and alkynes on the solid-phaseYAZHONG PEI; MOOS, W. H.Tetrahedron letters. 1994, Vol 35, Num 32, issn 0040-4039, 5745, 5825-5828 [5 p.]Article

Layered synthetic microstructure for soft x-ray spectroscopy of magnetically confined plasmas (invited)MOOS, W; ZWICKER, A. P; REGAN, S. P et al.Review of scientific instruments. 1990, Vol 61, Num 10, pp 2733-2737, issn 0034-6748, 5 p., part 2Conference Paper

Continued observations of the H Ly α emission from UranusCLARKE, J; DURRANCE, S; PRADHAN, A et al.JGR. Journal of geophysical research. Part A, Space physics. 1986, Vol 91, Num 8, pp 8771-8781Article

Nonprofit Pharma: Solutions to What Ails the IndustryMOOS, W. H; KODUKULA, K.Current medicinal chemistry. 2011, Vol 18, Num 22, pp 3437-3440, issn 0929-8673, 4 p.Conference Paper

Recent advances in the generation of chemical diversity librariesDESAI, M. C; ZUCKERMANN, R. N; MOOS, W. H et al.Drug development research. 1994, Vol 33, Num 2, pp 174-188, issn 0272-4391Article

Evaluation in rats of the somnogenic, pyrogenic, and central nervous system depressant effects of muramyl dipeptideMELTZER, L. T; SERPA, K. A; MOOS, W. H et al.Psychopharmacologia. 1989, Vol 99, Num 1, pp 103-108, issn 0033-3158Article

Cardiotonic agents. VII: Inhibition of separated forms of cyclic nucleotide phosphodiesterase from guinea pig cardiac muscle by 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and related compounds. Structure-activity relationships and correlation with in vivo positive inotropic activitySIRCAR, I; WEISHAAR, R. E; KOBYLARZ, D et al.Journal of medicinal chemistry (Print). 1987, Vol 30, Num 11, pp 1955-1962, issn 0022-2623Article

Efficient method for the preparation of peptoids [oligo(N-substituted glycines)] by submonomer solid-phase synthesisZUCKERMANN, R. N; KERR, J. M; KENT, S. B. H et al.Journal of the American Chemical Society. 1992, Vol 114, Num 26, pp 10646-10647, issn 0002-7863Article

Conformation of three tetrahydropyridinyl oxime cognition activatorsBANDOLI, G; DOLMELLA, A; MOOS, W. H et al.Journal of crystallographic and spectroscopic research. 1991, Vol 21, Num 4, pp 419-429, issn 0277-8068Article

Cognition activatorsMOOS, W. H; DAVIS, R. E; SCHWARZ, R. D et al.Medicinal research reviews (Print). 1988, Vol 8, Num 3, pp 353-391, issn 0198-6325Article

Cardiotonic agents. I: 4,5-Dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones: novel positive inotropic agents for the treatment of congestive heart failureBRISTOL, J. A; SIRCAR, I; MOOS, W. H et al.Journal of medicinal chemistry (Print). 1984, Vol 27, Num 9, pp 1099-1101, issn 0022-2623Article

Cardiotonic agents. VIII: Selective inhibitors of adenosine 3',5'-cyclic phosphate phosphodiesterase. III: Elaboration of a five-point model for positive inotropic activityMOOS, W. H; HUMBLET, C. C; SIRCAR, I et al.Journal of medicinal chemistry (Print). 1987, Vol 30, Num 11, pp 1963-1972, issn 0022-2623Article

Introduction to mitochondrial function and genomicsDYKENS, J. A; DAVIS, R. E; MOOS, W. H et al.Drug development research. 1999, Vol 46, Num 1, pp 2-13, issn 0272-4391Article

Measuring diversity : experimental design of combinatorial libraries for drug discoveryMARTIN, E. J; BLANEY, J. M; SIANI, M. A et al.Journal of medicinal chemistry (Print). 1995, Vol 38, Num 9, pp 1431-1436, issn 0022-2623Article

A silica gel plate-based qualitative assay for acetylcholinesterase activity : a mass method to screen for potential inhibitorsKIELY, J. S; MOOS, W. H; PAVIA, M. R et al.Analytical biochemistry. 1991, Vol 196, Num 2, pp 439-442, issn 0003-2697Article

Cardiotonic agents. X: Cardiovascular evaluation of dihydropyridazinone ring open analogues of imazodanSIRCAR, I; MOOS, W. H; MORRISON, G. C et al.European journal of medicinal chemistry. 1989, Vol 24, Num 4, pp 349-355, issn 0223-5234, 7 p.Article

Cholinergic agents : effect of methyl substitution in a series of arecoline derivatives on binding to muscarinic acetylcholine receptorsMOOS, W. H; BERGMEIER, S. C; THOMAS, A. J et al.Journal of pharmaceutical sciences. 1992, Vol 81, Num 10, pp 1015-1019, issn 0022-3549Article

Acetylcholine releasing agents as cognition activators. Chemistry and pharmacology of a series of ureasTHOMAS, A. J; KESTER, J. A; BUTLER, D. E et al.Cholinomimetics and Alzheimer's disease. Bioorganic & medicinal chemistry letters. 1992, Vol 2, Num 8, pp 855-860Book Chapter

Characterization of novel antimicrobial peptoidsGOODSON, B; EHRHARDT, A; GIACONA, M. B et al.Antimicrobial agents and chemotherapy. 1999, Vol 43, Num 6, pp 1429-1434, issn 0066-4804Article

A rationale for the design and synthesis of m1 selective muscarinic agonistsTECLE, H; LAUFFER, D. J; MIRZADEGAN, T et al.Cholinomimetics and Alzheimer's disease. Bioorganic & medicinal chemistry letters. 1992, Vol 2, Num 8, pp 821-826Book Chapter

Cholinergic agents: aldehyde, ketone, and oxime analogues of the muscarinic agonist UH5SANDERS, K. B; THOMAS, A. J; PAVIA, M. R et al.Cholinomimetics and Alzheimer's disease. Bioorganic & medicinal chemistry letters. 1992, Vol 2, Num 8, pp 803-808Book Chapter

N6-(2,2-diphenylethyl)adenosine, a novel adenosine receptor agonist with antipsychotic-like activityBRIDGES, A. J; MOOS, W. H; SZOTEK, D. L et al.Journal of medicinal chemistry (Print). 1987, Vol 30, Num 10, pp 1709-1711, issn 0022-2623Article

Ribose-modified adenosine analogues as adenosine receptor agonistsTAYLOR, M. D; MOOS, W. H; HAMILTON, H. W et al.Journal of medicinal chemistry (Print). 1986, Vol 29, Num 3, pp 346-353, issn 0022-2623Article

  • Page / 2